Transgene Biotek Ltd
TRABITransgene Biotek Ltd
TRABI
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -19.81 | 3.58 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 43.70 | 5.02 | 0.72% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Transgene Biotek is a biotechnology company which operates transgene medical centers. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics
Peers
Compare with peersBiocon Ltd
Hester Biosciences Ltd
Panacea Biotec Ltd
Zenotech Laboratories Ltd
Vivo Bio Tech Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.33 | 0.35 | 0.94 | 7.49 | 2.11 | 0.18 | 0.44 | 0.30 | 0.23 | 0.31 | ||||||||||
Raw Materials | 0.01 | 0.00 | 0.00 | 0.03 | 0.03 | 0.01 | 0.06 | -0.05 | 1.11 | 0.77 | ||||||||||
| Power & Fuel Cost | 0.16 | 0.10 | 0.12 | 0.06 | 0.06 | 0.16 | 0.01 | 0.01 | ||||||||||||
| Employee Cost | 1.04 | 0.68 | 0.55 | 0.33 | 0.25 | 0.29 | 0.25 | 0.29 | ||||||||||||
| Selling & Administrative Expenses | 0.59 | 0.47 | 0.20 | 0.25 | 0.35 | 0.37 | 0.27 | 0.27 | ||||||||||||
| Operating & Other expenses | 0.12 | 0.06 | 1.97 | 1.54 | 0.05 | 0.03 | 0.10 | 0.02 | ||||||||||||
EBITDA | -1.59 | -0.96 | -1.90 | 5.28 | 1.37 | -0.68 | -0.25 | -0.24 | -0.88 | -0.46 | ||||||||||
| Depreciation/Amortization | 17.18 | 20.50 | 17.53 | 9.89 | 9.89 | 9.90 | 9.91 | 9.92 | 4.95 | 2.52 | ||||||||||
| PBIT | -18.77 | -21.46 | -19.43 | -4.61 | -8.52 | -10.58 | -10.16 | -10.16 | -5.83 | -2.98 | ||||||||||
| Interest & Other Items | 0.36 | 0.07 | 0.43 | 1.03 | 0.26 | 0.38 | 0.27 | 0.23 | 0.18 | 0.16 | ||||||||||
| PBT | -19.13 | -21.53 | -19.86 | -5.64 | -8.78 | -10.96 | -10.43 | -10.39 | -6.01 | -3.14 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -19.13 | -21.53 | -19.86 | -6.43 | -8.78 | -10.96 | -10.43 | -10.39 | -6.01 | -3.14 | ||||||||||
| EPS | -2.52 | -2.84 | -2.62 | -0.85 | -1.16 | -1.45 | -1.38 | -1.37 | -0.79 | -0.41 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Transgene Biotek Ltd | -10.35 | 3.58 | — |
| Biocon Ltd | 61.19 | 1.26 | 0.64% |
| Hester Biosciences Ltd | 48.37 | 4.46 | 0.53% |
| Panacea Biotec Ltd | -29.26 | 1.16 | — |
Price Comparison
Compare TRABI with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
TRABI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Transgene Biotek reports consolidated net loss of Rs 2.60 crore in the September 2021 quarter
2 years ago•Business Standard
Transgene Biotek reports consolidated net loss of Rs 2.61 crore in the June 2021 quarter
2 years ago•Business Standard
Transgene Biotek reports consolidated net loss of Rs 2.61 crore in the March 2021 quarter
2 years ago•Business Standard
Transgene Biotek reports consolidated net loss of Rs 2.52 crore in the December 2020 quarter
2 years ago•Business Standard
BRIEF-Transgene Biotek Says Board Approves Licensing Of TrabiORAL To GVK Bio - Investing.com India
3 years ago•Investing.com
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -50.17%, vs industry avg of 19.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.15% to 0%